EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:749530 - hyaluronidase (human recombinant)
| ChEBI ID | CHEBI:749530 |
| ChEBI Name | hyaluronidase (human recombinant) |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. |
| Applications: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anti-inflammatory agent Any compound that has anti-inflammatory effects. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. hypoglycemic agent A drug which lowers the blood glucose level. antipsoriatic A drug used to treat psoriasis. bone density conservation agent An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role analgesic (CHEBI:35480) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role anti-HIV agent (CHEBI:64946) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role anti-inflammatory agent (CHEBI:67079) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role antineoplastic agent (CHEBI:35610) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role antipsoriatic (CHEBI:50748) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role bone density conservation agent (CHEBI:50646) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role dermatologic drug (CHEBI:50177) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role hypoglycemic agent (CHEBI:35526) |
| hyaluronidase (human recombinant) (CHEBI:749530) has role immunosuppressive agent (CHEBI:35705) |
| hyaluronidase (human recombinant) (CHEBI:749530) is a organic molecular entity (CHEBI:50860) |
| INNs | Source |
|---|---|
| vorhialuronidasa alfa | WHO MedNet |
| vorhyaluronidase alfa | WHO MedNet |
| Synonyms | Source |
|---|---|
| Chemophase | ChEMBL |
| Enhanze | ChEMBL |
| Human hyaluronidase | ChEMBL |
| Hyaluronidase fihj | ChEMBL |
| Hyaluronidase-fihj | ChEMBL |
| Hyaluronidase (human) | ChEMBL |
| Brand Names | Source |
|---|---|
| Cumulase | ChEMBL |
| Hyaluronidase (human recombinant) component of lispro-ph20 rhuph20 | ChEMBL |
| Hylenex | ChEMBL |
| Hylenex recombinant | ChEMBL |